Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 886982 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,280,223
+$637,010 QoQ
Shares Held
916,536
+3.9% QoQ
Ownership
0.924%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 89 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. XFOR ranks #200 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in XFOR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,280,223 916,536
2026-03-31 $3,643,213 882,134
2025-12-31 $3,327,560 831,890
2025-06-30 $35,841 18,864
2025-03-31 $64,631 273,865
2024-12-31 $350,585 477,638
2024-09-30 $195,739 292,585
2024-06-30 $99,289 171,190
2024-03-31 $1,471,911 1,058,930
2023-12-31 $61,068 72,788
2023-09-30 $54,056 49,593
2023-06-30 $648,815 334,441
2023-03-31 $72,629 83,482
2022-12-31 $54,595 54,980
2022-09-30 $94,699 55,380
2021-12-31 $47,972 20,949
2021-09-30 $55,412 10,475
2021-06-30 $351,045 54,007
2021-03-31 $714,948 83,037
2020-12-31 $360,118 56,006
2020-09-30 $348,099 51,418
2020-06-30 $294,353 31,583
2020-03-31 $141,499 14,150